2 unknown. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Dextromethorphan: new trials by email Literature Review of Dextromethorphan trials Research Report on Dextromethorphan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dextromethorphan, Memantine Monotherapy, or Combined Use of Dextromethorphan and Memantine in Amphetamine Addiction Dextromethorphan, Memantine, Dextromethorphan and memantine - Amphetamine Addiction, Pharmacotherapy | Phase 2 / Phase 3 | Unknown | National Cheng-Kung University Hospital | 120 | 2020-08-11 | 2020-12-29 |
| Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination Direct Current Stimulation, Dextromethorphan - Schizophrenia | Phase 1 / Phase 2 | Unknown | University of Ottawa | 12 | 2015-04-01 | 2015-04-27 |
Amphetamine-Related Disorders (1) · Inflammation (1) · Nerve Degeneration (1) · Schizophrenia (1)
National Cheng-Kung University Hospital (1) · University of Ottawa (1)
Canada (1) · Taiwan (1)
Danielle Impey, Ph.D. (cand.) (1) · Tzu-Yun Wang (1)